The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Seven-year overall survival analysis from ECHELON-1 study of A+AVD versus ABVD in patients with previously untreated stage III/IV classical Hodgkin lymphoma.
 
Stephen M. Ansell
Honoraria - Answers in CME; Medscape; Research to Practice; WebMD
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); Regeneron (Inst); Seagen (Inst); Step Pharma (Inst); Takeda (Inst)
 
David J. Straus
No Relationships to Disclose
 
Joseph M. Connors
No Relationships to Disclose
 
Wojciech Jurczak
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Lilly; Takeda
Research Funding - Abbvie; AstraZeneca; BeiGene; Lilly; Takeda
 
Won-Seog Kim
Honoraria - Takeda
Research Funding - BeiGene; Boryung; Celltrion; Merck; Pfizer; Roche; Sanofi
 
Andrea Gallamini
Honoraria - Takeda
Speakers' Bureau - Takeda
Travel, Accommodations, Expenses - Takeda
 
Radhakrishnan Ramchandren
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Pharmacyclics/Janssen; Sandoz-Novartis; Seagen; Seattle Genetics/Pfizer
Speakers' Bureau - GlaxoSmithKline
Research Funding - Collectar Therapeutics (Inst); Curis (Inst); Genentech (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)
 
Jonathan W. Friedberg
Research Funding - Enterome (Inst)
Patents, Royalties, Other Intellectual Property - Patient on bone marrow microenvironment signals (I)
 
Ranjana H. Advani
Consulting or Advisory Role - ADC Therapeutics; Autolus; BeiGene; Bristol-Myers Squibb/Celgene; Genentech/Roche; Merck
Research Funding - AstraZeneca (Inst); BeiGene (Inst); cyteir (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Janssen (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Regeneron (Inst); Seagen (Inst)
 
Martin Hutchings
Consulting or Advisory Role - Abbvie; Genmab; Janssen; Roche; Takeda
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Celgene (Inst); Genmab (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
 
Andrew M. Evens
Honoraria - Abbvie; Cota; Curio/Vaniam Group; Epizyme; HUTCHMED; Incyce; Novartis; OncLive; Pharmacyclics; Research to Practice; SeaGen
 
Kerry J. Savage
Honoraria - Abbvie; Bristol-Myers Squibb; Janssen Oncology; Seagen
Consulting or Advisory Role - Bristol-Myers Squibb; Seagen
Research Funding - Bristol Myers Squibb (Inst); Roche (Inst)
(OPTIONAL) Uncompensated Relationships - AstraZeneca; Beigene; Regeneron
 
Hyeon-Seok Eom
No Relationships to Disclose
 
Tatyana A Feldman
Stock and Other Ownership Interests - Genomic Testing Cooperative; OM Pharmaceutical Industries
Honoraria - ADC Therapeutics; AstraZeneca; Bristol Myers Squibb; Epizyme; Genmab; Pharmacyclics; SeaGen; Takeda
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; Bristol-Meyers Squibb; Epizyme; Genmab; Pharmacyclics; Seagen
Speakers' Bureau - Genmab; Seagen; Takeda
Research Funding - ADC Therapeutics (Inst); Alexion Pharmaceuticals (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Daiichi (Inst); Genmab; Kymera (Inst); Merck (Inst); Portola Pharmaceuticals (Inst); Seagen (Inst); Tessa Therapeutics (Inst); Trillium Therapeutics (Inst)
 
Jeremy S. Abramson
Honoraria - Abbvie; AstraZeneca; Bristol-Myers Squibb/Celgene; Janssen; Kite, a Gilead company; Regeneron
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Alimera Sciences; AstraZeneca; BeiGene; Bluebird Bio; Bristol-Myers Squibb; C4 Therapeutics; Caribou Biosciences; Celgene; Cellectar; Century Therapeutics; EMD Serono; Epizyme; Genmab; Incyte; Interius Biotherapeutics; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Kymera; Lilly; MorphoSys; MorphoSys; MustangBio; Novartis; Ono Pharmaceutical; Roche/Genentech; Seagen; Takeda
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Cellectis (Inst); Merck (Inst); MustangBio (Inst); Regeneron (Inst); Seagen (Inst)
 
Cassie Dong
No Relationships to Disclose
 
Bipin N. Savani
Employment - Takeda; Vanderbilt University Medical Center
Stock and Other Ownership Interests - Takeda
 
Athanasios Zomas
Employment - Takeda Pharma International
 
Keenan Fenton
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
John Radford
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline; Johnson and Johnson (I); Smith & Nephew (I)
Honoraria - ADC Therapeutics; Takeda
Consulting or Advisory Role - Novartis; Seagen; SOBI; Takeda
Speakers' Bureau - Novartis; Seagen; Takeda
Research Funding - Takeda
Travel, Accommodations, Expenses - ADC Therapeutics; Takeda